Gujarat Terce Laboratories Ltd — Updates, 26-05-2025: Company Update

Gujarat Terce Laboratories Limited has announced a board meeting to discuss the financial results for the quarter and half-year ended March 31, 2025. The company reported a 1% revenue increase to ₹12.32 crore in Q4 FY25 with EBITDA rising 5% to ₹1.14 crore, but posted a net loss of ₹3.39 crore compared to a profit last year. For FY25, revenue grew 4.63% to ₹50.20 crore, and EBITDA surged 164% to ₹4.19 crore, reflecting better operational efficiency and financial discipline. Management highlighted improved cash flow, optimized inventory, and reduced expiry losses, along with closure of past tax disputes. The company aims for sustained long-term growth driven by strategic brand focus and strengthened execution.